A former entrepreneur and practicing physician, Steve knows firsthand the challenges of building successful healthcare companies. Unfazed by the complexity in healthcare, whether regulatory, technical or market driven, Steve's mission at Canaan Partners has been to invest in companies that make healthcare delivery more effective.
As an investor and board member, Steve has served in all capacities in public and private companies. Roles have included executive chairman and chair of compensation, governance and audit committees. He brings a broad view of entrepreneurial opportunities in a time of rapid technological change and changing markets. Steve is particularly attuned to go to market strategies and navigating complex regulatory and reimbursement requirements.
Steve currently serves on the boards of companies in digital health (Truveris, Ambra Health, Corvium and Genome Medical), biopharma (Liquidia (LQDA - NASDAQ)) and medical devices (Onkos Surgical and Mitraspan). Past investments include Advanced BioHealing (Shire), Envisia (Aerie) and public companies Marinus Pharmaceuticals (MRNS-NASDAQ) and Amicus Therapeutics (FOLD-NASDAQ).
Before joining Canaan in 2002, Steve founded multiple start-ups, including Radiology Management Sciences (RMS), a pioneer in managing radiology benefits for health plans, where he was CEO for 6 years. Steve also helped start OmniSonics Medical Technologies, which engineered novel ultrasonic catheters for treating vascular occlusive disease, and co-founded TeleRad, an early teleradiology services company. Previously, Steve was a strategic consultant for Arthur D. Little. Steve was an Ewing Marion Kauffman Fellow, an educational program to develop future leaders in venture capital.
Steve obtained his AB from Dartmouth College, a MA in the history of science and public policy from Harvard, and his medical degree from the University of Rochester. Steve completed his residency at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine).